Castro-Guijarro, A.C.; Vanderhoeven, F.; Mondaca, J.M.; Redondo, A.L.; Zoppino, F.C.M.; Fernandez-Muñoz, J.M.; Sanchez, A.M.; Flamini, M.I.
Combination Treatment of Retinoic Acid Plus Focal Adhesion Kinase Inhibitor Prevents Tumor Growth and Breast Cancer Cell Metastasis. Cells 2022, 11, 2988.
https://doi.org/10.3390/cells11192988
AMA Style
Castro-Guijarro AC, Vanderhoeven F, Mondaca JM, Redondo AL, Zoppino FCM, Fernandez-Muñoz JM, Sanchez AM, Flamini MI.
Combination Treatment of Retinoic Acid Plus Focal Adhesion Kinase Inhibitor Prevents Tumor Growth and Breast Cancer Cell Metastasis. Cells. 2022; 11(19):2988.
https://doi.org/10.3390/cells11192988
Chicago/Turabian Style
Castro-Guijarro, Ana Carla, Fiorella Vanderhoeven, Joselina Magali Mondaca, AnalÃa Lourdes Redondo, Felipe Carlos Martin Zoppino, Juan Manuel Fernandez-Muñoz, Angel Matias Sanchez, and Marina Inés Flamini.
2022. "Combination Treatment of Retinoic Acid Plus Focal Adhesion Kinase Inhibitor Prevents Tumor Growth and Breast Cancer Cell Metastasis" Cells 11, no. 19: 2988.
https://doi.org/10.3390/cells11192988
APA Style
Castro-Guijarro, A. C., Vanderhoeven, F., Mondaca, J. M., Redondo, A. L., Zoppino, F. C. M., Fernandez-Muñoz, J. M., Sanchez, A. M., & Flamini, M. I.
(2022). Combination Treatment of Retinoic Acid Plus Focal Adhesion Kinase Inhibitor Prevents Tumor Growth and Breast Cancer Cell Metastasis. Cells, 11(19), 2988.
https://doi.org/10.3390/cells11192988
